Last updated: July 3, 2024
Sponsor: Icahn School of Medicine at Mount Sinai
Overall Status: Active - Not Recruiting
Phase
1
Condition
Cardiac Surgery
Treatment
Bupivacain
PIF block
Ultrasound
Clinical Study ID
NCT04985500
STUDY-20-01473
Ages 18-85 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adults 18-85 years old
Scheduled to undergo cardiac procedures involving sternotomy
All genders
Exclusion
Exclusion Criteria:
ASA class V
Urgent or emergent surgery
Contraindications to administration of local anesthesia (e.g. local anestheticallergy)
History of substance abuse or chronic opioid use
Patient refusal or inability to consent
Study Design
Total Participants: 225
Treatment Group(s): 4
Primary Treatment: Bupivacain
Phase: 1
Study Start date:
July 09, 2021
Estimated Completion Date:
December 31, 2024
Connect with a study center
Mount Sinai Morningside Hospital
New York, New York 10025
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.